Cancer Guidelines Database

Access quality cancer guidelines from a single Canadian source

We've listed guidelines under your selection of "Type of cancer". The most recent guidelines are first.

Diagnosis and Empirical Treatment of Fever of Unknown Origin (FUO) in Adult Neutropenic Patients: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society Of Hematology and Medical Oncology (DGHO)

Year: 2017
AGREE II score: Unavailable
Developer organization: German Society of Hematology and Medical Oncology (DGHO)
This is a clinical practice guideline for fever of unknown origin (FUO) in adult neutropenic patients. The guideline updates recommendations for diagnosis and empirical therapy of these patients in light of the challenges of antimicrobial stewardship. Specific recommendations are provided for taking down patient history and performing a physical examination, ordering chest radiograph, and taking nasal/pharyngeal (MRSA) or rectal (VRE) swabs.

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

Year: 2018
AGREE II score: Available
Developer organization: American Society of Clinical Oncology
This is a clinical practice guideline on the use of erythropoiesis-stimulating agents (ESAs) and biosimilars for the management of cancer-associated anemia in adult patients. Outcomes of interest include mortality, frequency of RBC transfusion, thromboembolic risk, quality of life, fatigue, progression-free survival and overall survival. In the case of biosimilars, hemoglobin (HgB) response and immunogenicity were additional outcomes of interest. Patient counselling and talking tips are also included to help clinicians implement the guideline's recommendations.

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Year: 2019
AGREE II score: Available
Developer organization: American Society of Clinical Oncology
This is a clinical practice guideline for patients with multiple myeloma. The guideline provides recommendations for the treatment of both newly diagnosed and relapsed patients. Outcomes of interest include overall survival, progression-free survival, response rate, and quality of life.

WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents

Year: 2018
AGREE II score: Available
Developer organization: World Health Organization
This is a clinical practice guideline for adult and adolescent cancer patients who are experiencing cancer-related pain. The guideline examines various pharmacological and radiotherapeutic management options. Topics of interest include initiation of pain relief, maintenance of pain relief with opioids, cessation of opioids, and the use of radiotherapy.

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association

Year: 2017
AGREE II score: Available
Developer organization: American Physical Therapy Association
This is a clinical practice guideline for adult patients who have undergone cancer treatment, and are at risk for developing secondary upper quadrant lymphedema (SUQL). The guideline provides recommendations for the diagnosis of SUQL, using methods such as clinical examination and patient-reported symptom assessments, bioimpedance analysis, circumferential measurement, water displacement, and imaging techniques such as magnetic resonance imaging (MRI), and computed tomography (CT). The primary outcomes of interest are decreases in both morbidity as well as activity and participation restrictions, and an increase in overall quality of life (QOL).

Guidelines for the Prophylaxis of Pneumocystis Jirovecii Pneumonia (PJP) in Children With Solid Tumours

Year: 2016
AGREE II score: Available
Developer organization: Children's Cancer and Leukaemia Group
This is a clinical practice guideline on the indications and methods for prophylaxis against Pneumocystis jirovecii pneumonia (PCP) in pediatric oncology patients undergoing treatment for solid malignancies. Recommendations are provided for the following patient populations: those receiving corticosteroids, temozolamide, or radiotherapy in combination with corticosteroids and/or chemotherapy, or rituximab in combination with other cancer treatments (e.g. chemotherapy, radiotherapy, corticosteroids), as well as those with underlying lung pathology or previous PCP.

European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) Recommendations for the Surgical Management of Adrenocortical Carcinoma

Year: 2017
AGREE II score: Available
Developer organization: European Society of Endocrine Surgeons
This is a clinical practice guideline on the perioperative care of patients undergoing surgery for adrenocortical carcinoma (ACC). Topics covered in the guideline include the optimal preoperative investigations, surgical approach, quality criteria of the operative note and pathological report, follow-up after surgery, surgical management of metastatic and/or recurrent ACC, and debulking or palliative surgery. The guideline also emphasizes the need for inclusion in collaborative and/or prospective databases to advance research and evidence on the topic.

International Clinical Practice Guidelines Including Guidance for Direct Oral Anticoagulants in the Treatment and Prophylaxis of Venous Thromboembolism in Patients With Cancer

Year: 2016
AGREE II score: Available
Developer organization: International Initiative on Thrombosis and Cancer
This is a clinical practice guideline for the management of venous thromboembolism (VTE) in patients with cancer. The guideline examines the use of direct oral anticoagulants (DOACs) for the treatment of VTE. Topics of interest include initial treatment of VTE, maintenance, long-term treatment, and recurrence.

SEOM Clinical Guideline of Management of Soft-Tissue Sarcoma (2016)

Year: 2016
AGREE II score: Unavailable
Developer organization: Spanish Society of Medical Oncology
This is a clinical practice guideline for patients with soft-tissue sarcoma (STS). The guideline examines the therapeutic decision-making processes used for the management of STS in order to improve patient care. Recommendations are provided for staging, diagnosis, and treatment.

Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline

Year: 2018
AGREE II score: Available
Developer organization: American Society of Clinical Oncology
This is a clinical practice guideline for adult and pediatric patients with cancer. The guideline examines the practicality of palliative care delivery models for these patients and their family caregivers in resource-constrained settings. Recommendations are provided for palliative care models at the district, regional, and national level, as well as in the primary health care setting. For each model, the timing for addressing palliate care needs as well as the workforce, knowledge, and skills required are discussed. Nurses' roles in pain management, as well as spiritual care, social work/counseling, and opioid availability are also considered.